These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. Villers D; Dao T; Nguyen JM; Bironneau E; Godard A; Moreau M; De Groote D; Nicolas F; Soulillou JP; Anegon I J Infect Dis; 1995 Jan; 171(1):232-6. PubMed ID: 7798671 [TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. Waring P; Wycherley K; Cary D; Nicola N; Metcalf D J Clin Invest; 1992 Nov; 90(5):2031-7. PubMed ID: 1430224 [TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Waring PM; Waring LJ; Billington T; Metcalf D Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1337-41. PubMed ID: 7877978 [TBL] [Abstract][Full Text] [Related]
6. ELISA detection of circulating levels of LIF, OSM, and CNTF in septic shock. Guillet C; Fourcin M; Chevalier S; Pouplard A; Gascan H Ann N Y Acad Sci; 1995 Jul; 762():407-9. PubMed ID: 7668543 [No Abstract] [Full Text] [Related]
7. Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies. Lorgeot V; Trimoreau F; Gachard N; Praloran V; Denizot Y Eur Cytokine Netw; 1997 Mar; 8(1):57-9. PubMed ID: 9110149 [TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism. Ren SG; Seliktar J; Li X; Hershman JM; Braunstein GD; Melmed S J Clin Endocrinol Metab; 1999 Aug; 84(8):2883-7. PubMed ID: 10443695 [TBL] [Abstract][Full Text] [Related]
9. Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. Ren SG; Seliktar J; Li X; Braunstein GD; Melmed S J Clin Endocrinol Metab; 1998 Apr; 83(4):1275-83. PubMed ID: 9543156 [TBL] [Abstract][Full Text] [Related]
10. Sepsis and serum cytokine concentrations. Damas P; Canivet JL; de Groote D; Vrindts Y; Albert A; Franchimont P; Lamy M Crit Care Med; 1997 Mar; 25(3):405-12. PubMed ID: 9118654 [TBL] [Abstract][Full Text] [Related]
11. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients. Morel D; Taupin JL; Combe C; Potaux L; Gualde N; Moreau JF Transplantation; 1994 Dec; 58(11):1190-5. PubMed ID: 7992361 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of blood cytokine concentrations in patients with bacteremic infections. Kragsbjerg P; Holmberg H; Vikerfors T Scand J Infect Dis; 1996; 28(4):391-8. PubMed ID: 8893405 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. Halstensen A; Ceska M; Brandtzaeg P; Redl H; Naess A; Waage A J Infect Dis; 1993 Feb; 167(2):471-5. PubMed ID: 8421185 [TBL] [Abstract][Full Text] [Related]
14. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha. Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813 [TBL] [Abstract][Full Text] [Related]
15. Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies. Lorgeot V; Praloran V; Turlure P; Denizot Y Leukemia; 1997 Feb; 11(2):311-2. PubMed ID: 9009099 [No Abstract] [Full Text] [Related]
16. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity. Viallard JF; Taupin JL; Miossec V; Pellegrin JL; Moreau BL Eur Cytokine Netw; 1999 Mar; 10(1):17-24. PubMed ID: 10210768 [TBL] [Abstract][Full Text] [Related]
17. Sequential production of leukaemia inhibitory factor by blood cell culture in patients with ARDS. Gruson D; Hilbert G; Juzan M; Taupin JL; Coulon V; Moreau JF; Gualde N; Gbikpi-Benissan G Intensive Care Med; 1998 Apr; 24(4):366-8. PubMed ID: 9609417 [TBL] [Abstract][Full Text] [Related]
18. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma. Wierzbowska A; Urbańska-Ryś H; Robak T Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412 [TBL] [Abstract][Full Text] [Related]